
Celemics, Inc. — Investor Relations & Filings
Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주요사항보고서(유상증자결정) | 2026-05-21 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2026-05-12 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-05-08 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-07 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-07 | Korean |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46726114 | [기재정정]주요사항보고서(유상증자결정) | 2026-05-21 | Korean | ||
| 46362816 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 45154650 | [기재정정]주요사항보고서(유상증자결정) | 2026-05-12 | Korean | ||
| 43872782 | 주식등의대량보유상황보고서(약식) | 2026-05-08 | Korean | ||
| 42372145 | 주식등의대량보유상황보고서(일반) | 2026-05-07 | Korean | ||
| 42371922 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-07 | Korean | ||
| 41760605 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | ||
| 41751513 | 주식등의대량보유상황보고서(일반) | 2026-05-06 | Korean | ||
| 39056797 | 기업설명회(IR)개최 | 2026-04-30 | Korean | ||
| 39034176 | 증권발행결과(자율공시) | 2026-04-30 | Korean | ||
| 38424821 | [기재정정]증권발행결과(자율공시) | 2026-04-29 | Korean | ||
| 38424772 | [기재정정]증권발행결과(자율공시) | 2026-04-29 | Korean | ||
| 38258404 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-04-29 | Korean | ||
| 37929249 | 증권발행결과(자율공시) | 2026-04-28 | Korean | ||
| 35175914 | [기재정정]주요사항보고서(유상증자결정) | 2026-04-22 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
China Isotope & Radiation Corporation
Develops and distributes radioisotope and radiation technol…
|
1763 | HK | Manufacturing |
|
China Medical System Holdings Limited
Innovation-driven specialty pharmaceutical group engaged in…
|
867 | KY | Manufacturing |
|
China NT Pharma Group Company Limited
Engaged in biotech R&D, manufacturing, sales, and marketing…
|
1011 | HK | Manufacturing |
|
CHINA PHARMA HOLDINGS, INC.
Develops, manufactures, and markets prescription, OTC, and …
|
CPHI | US | Manufacturing |
|
China Regenerative Medicine International Limited
Develops, produces, and sells tissue engineering and regene…
|
8158 | HK | Manufacturing |
|
China Resources Boya Bio-pharmaceutical Group Co., Ltd
Researches and produces blood products and plasma-derived m…
|
300294 | CN | Manufacturing |
|
China Resources Double-Crane Pharmaceutical Co.,Ltd.
Develops and manufactures chronic disease medications and p…
|
600062 | CN | Manufacturing |
|
CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO.,LTD
Develops and produces OTC medicines, TCM, and supplements f…
|
600750 | CN | Manufacturing |
|
China Resources Pharmaceutical Group Limited
Integrated pharmaceutical value chain encompassing R&D, man…
|
3320 | HK | Manufacturing |
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Develops and sells consumer healthcare and prescription dru…
|
000999 | CN | Manufacturing |
Celemics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16444/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16444 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16444 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16444 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16444}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celemics, Inc. (id: 16444)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.